Niagen Bioscience to Present at the Sixth Annual Longevity Summit Taking Place at the Buck Institute for Research on Aging
Business Wire•16/11/2026•08:32 ET
2
Key Highlights
- ➤Dec. 9-10, 2026: Niagen Bioscience to present research at Buck Institute Longevity Summit
- ➤320+ research agreements across 30+ countries underpin Niagen’s NAD+ research program
- ➤240+ peer-reviewed publications include 50+ clinical studies on Niagen
- ➤MGB prevention trial proposed for adults 50+, with design details pending final agreements
- ➤NB4168 advances as investigational oral candidate for Ataxia-Telangiectasia
Expert Statements
Abhijit Kale, Senior Director of Global External Research at Niagen Bioscience
“The Future of Medicine: Eliminating Diseases of Aging”
Niagen Bioscience to Present at the Sixth Annual Longevity Summit Taking Place at the Buck Institute for Research on Aging
Dr. Abhijit Kale to outline the next phase of the Niagen Research Program
Get started
Create a free account to read the full story.
